Spine BioPharma to Present at Piper Sandler Healthcare Conference
21 Nov 2024 //
BUSINESSWIRE
Spine BioPharma Completes Phase 3 Enrollment for SB-01 Trial
24 Sep 2024 //
BUSINESSWIRE
Spine BioPharma Partners With Ensol To Expand SB-01 Indications
10 Jul 2024 //
PR NEWSWIRE
Non-opioid drug developer snags PhIII funds; aTyr and Spruce line up capital
09 Feb 2023 //
ENDPTS
Spine BioPharma Announces First Patient Treated in U.S. Phase 3 Clinical Study
07 Sep 2022 //
PRNEWSWIRE
Spine BioPharma Initiating U.S. Phase 3 Clinical Study
11 May 2022 //
PRNEWSWIRE